This page includes the latest FDA filings for Intercept Pharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | ICPT | DUNS 966658416 |
Device Company | Device | Date |
---|---|---|
Intercept Pharmaceuticals Inc, Pharmacia & Upjohn Company LLC | Prescription Medication | 2024-11-09 |
Intercept Pharmaceuticals Inc, Pharmacia & Upjohn Company LLC | Prescription Medication | 2022-10-21 |
Intercept Pharmaceuticals Inc, Pharmacia & Upjohn Company LLC | Prescription Medication | 2022-05-24 |
Intercept Pharmaceuticals Inc, Pharmacia & Upjohn Company LLC | Prescription Medication | 2022-04-26 |
Intercept Pharmaceuticals Inc, Pharmacia & Upjohn Company LLC | Prescription Medication | 2022-03-05 |
Intercept Pharmaceuticals Inc, Pharmacia & Upjohn Company LLC | Prescription Medication | 2021-06-06 |
Intercept Pharmaceuticals Inc, Pharmacia & Upjohn Company LLC | Prescription Medication | 2020-02-07 |
Intercept Pharmaceuticals Inc, Pharmacia & Upjohn Company LLC | Prescription Medication | 2020-01-30 |
Intercept Pharmaceuticals Inc, Pharmacia & Upjohn Company LLC | Prescription Medication | 2018-03-09 |
Intercept Pharmaceuticals Inc | Ocaliva | 2016-05-27 |
Intercept Pharmaceuticals Inc | Ocaliva | 2016-05-27 |
NCAGE Code | 7MWA6 | INTERCEPT PHARMACEUTICALS, INC.!DBA INTERCEPT |
CAGE Code | 7MWA6 | INTERCEPT PHARMACEUTICALS, INC. INTERCEPT |
S.A.M. Registration | 7MWA6 [966658416] | INTERCEPT PHARMACEUTICALS, INC. INTERCEPT |
SEC | 0001270073 | INTERCEPT PHARMACEUTICALS, INC. of DELAWARE |